Stocks
Infinity Pharmaceuticals, Inc.INFI
NASDAQHealthcareBiotechnology$0.01-52.38%
Price as of · delayed, not real-time
Focused on developing novel therapies for difficult-to-treat cancers, this biopharmaceutical company specializes in small molecule drugs targeting immune and metabolic pathways. Investors monitor its clinical-stage pipeline, particularly its lead candidate eganelisib for immuno-oncology applications, given its potential in combination therapies.
Market Cap: $726,08952W Range: $0.01 – $1.30
Congressional Interest in Infinity Pharmaceuticals, Inc. (INFI)
2 members of Congress have disclosed 2 trades in Infinity Pharmaceuticals, Inc. (INFI), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
1
Sells
1
Who in Congress Is Trading INFI?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-12 | Roger W. Marshall | buy | $1K – $15K |
| 2016-10-14 | JAMES B. RENACCI | sell | $1K – $15K |